Targeted Reduction in Body Mass Index Is a Worthwhile Risk Reduction Strategy for Prostate Cancer.
作者信息
Thomas Charles R
出版信息
JAMA Oncol. 2015 Jun;1(3):349. doi: 10.1001/jamaoncol.2015.0514.
PMID:26181185
Abstract
摘要
相似文献
1
Targeted Reduction in Body Mass Index Is a Worthwhile Risk Reduction Strategy for Prostate Cancer.
JAMA Oncol. 2015 Jun;1(3):349. doi: 10.1001/jamaoncol.2015.0514.
2
Re: Difference in Association of Obesity with Prostate Cancer Risk between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
J Urol. 2016 Mar;195(3):627-8. doi: 10.1016/j.juro.2015.12.017. Epub 2015 Dec 10.
3
Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
JAMA Oncol. 2015 Jun;1(3):342-9. doi: 10.1001/jamaoncol.2015.0513.
4
Vitamins A and E: further clues for prostate cancer prevention.
J Natl Cancer Inst. 1998 Mar 18;90(6):414-5. doi: 10.1093/jnci/90.6.414.
5
Selenium, vitamin E, and prostate cancer--ready for prime time?
J Natl Cancer Inst. 1998 Aug 19;90(16):1184-5. doi: 10.1093/jnci/90.16.1184.
6
Vitamin E reduces prostate cancer rates in Finnish trial: U.S. considers follow-up.
J Natl Cancer Inst. 1998 Mar 18;90(6):416-7. doi: 10.1093/jnci/90.6.416.
7
Selenium and Vitamin E Cancer Prevention Trial--this one's for us.
J Natl Med Assoc. 2002 Sep;94(9):856-8.
8
First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statement.
J Urol. 2004 Feb;171(2 Pt 2):S3-4. doi: 10.1097/01.ju.0000107100.06725.51.
9
Prostate Cancer Disparity, Chemoprevention, and Treatment by Specific Medicinal Plants.
Nutrients. 2019 Feb 4;11(2):336. doi: 10.3390/nu11020336.
10
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
J Natl Cancer Inst. 2005 Jan 19;97(2):94-102. doi: 10.1093/jnci/dji009.
Zotero 插件